Dishman Carbogen Amcis has raised Rs 18 crore through allotment of Non-Convertible Debentures (NCDs) on private placement basis. The Management Committee of Board of Directors of the company in its meeting held on June 9, 2026, has allotted 1,800 senior, secured, rated, listed, transferable, redeemable, taxable NCDs of Rs 1,00,000 each at par for cash. The final maturity date of the NCDs is December 9, 2027.
Dishman Carbogen Amcis (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators.
